Today: 26 June 2026

Khadija Saeed

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Day One Biopharmaceuticals, Inc. Buyout: Why Servier’s $2.5 Billion Ojemda Deal Matters Now

Day One Biopharmaceuticals, Inc. Buyout: Why Servier’s $2.5 Billion Ojemda Deal Matters Now

Day One Biopharmaceuticals shares traded at $21.24 Monday, just below Servier’s $21.50-per-share cash offer in a $2.5 billion takeover. The deal would give Servier Ojemda, the only U.S.-approved single-drug treatment for pediatric low-grade glioma, with 2025 sales of $155.4 million. The tender offer has not started and closing depends on shareholder response and U.S. antitrust clearance.
W&T Offshore earnings: 2025 loss widens after delay as debt falls, offshore rule relief looms

W&T Offshore earnings: 2025 loss widens after delay as debt falls, offshore rule relief looms

W&T Offshore reported a preliminary 2025 net loss of $150.1 million, up from $87.1 million in 2024, as revenue dropped to $501.5 million and free cash flow plunged to $1.5 million. Average oil selling price fell to $64.09 a barrel, though production slightly increased. Year-end liquidity rose to $184.5 million, and net debt declined. The company warned results are unaudited and may change before its March 16 filing.
Reviva Pharmaceuticals Holdings (RVPH) Starts 1-for-20 Reverse Split as Nasdaq Deadline Nears

Reviva Pharmaceuticals Holdings (RVPH) Starts 1-for-20 Reverse Split as Nasdaq Deadline Nears

Reviva Pharmaceuticals enacted a 1-for-20 reverse stock split early Monday to boost its share price and avoid a Nasdaq delisting. The company faces a March 27 deadline to meet the $1 minimum bid rule. Reviva is also seeking funding for a new Phase 3 trial of its schizophrenia drug after the FDA requested more data. Analyst Jason Kolbert downgraded the stock, citing unchanged fundamentals.
9 March 2026
uniQure stock jolts higher again after FDA biologics chief set to exit

uniQure stock jolts higher again after FDA biologics chief set to exit

uniQure shares surged 34% to $14.27 in U.S. premarket trading Monday after news that FDA biologics chief Vinay Prasad will step down in April. The move follows a dispute over the agency’s demand for a new sham-surgery trial of uniQure’s Huntington’s gene therapy. The FDA has not agreed to approve the treatment based on current data. uniQure ended 2025 with $622.5 million in cash and investments.
9 March 2026
Oil Tops $100, Wall Street Futures Slide as Shock U.S. Jobs Data and Iran War Rattle Markets

Oil Tops $100, Wall Street Futures Slide as Shock U.S. Jobs Data and Iran War Rattle Markets

Brent crude topped $100 a barrel for the first time since 2022 as the U.S.-Israeli war with Iran disrupted the Strait of Hormuz and Gulf states cut oil output. S&P 500 futures fell 1.2% after a weak U.S. jobs report, while the VIX volatility index hit its highest since April 2025. Hundreds of tankers remained idle, and G7 finance ministers discussed a possible coordinated release of emergency oil reserves.
9 March 2026
3D Systems Corporation beats Q4 sales guidance, but weak Q1 outlook clouds recovery

3D Systems Corporation beats Q4 sales guidance, but weak Q1 outlook clouds recovery

3D Systems reported fourth-quarter revenue of $106.3 million, up 16% from the prior quarter and above its forecast, but still down 4% from a year earlier. Full-year revenue dropped 12% to $386.9 million, with a net income gain driven by asset sales and cost cuts. Healthcare Solutions rose 25% while Industrial Solutions fell 21%. The company expects a first-quarter revenue decline and continued losses.
Aureus Greenway Holdings to Buy Powerus in Drone Pivot, With $9 Million Raise

Aureus Greenway Holdings to Buy Powerus in Drone Pivot, With $9 Million Raise

Aureus Greenway Holdings will acquire drone maker Powerus in an all-stock deal to take it public, renaming the combined company Powerus Corp and targeting a summer 2026 Nasdaq listing as PUSA. South Korea's KCGI committed to buy $50 million in Powerus stock, while Aureus arranged $9 million in new financing. The deal still requires SEC and shareholder approval. AGH shares rose 12.8% in premarket trading.
9 March 2026
Visa’s next stablecoin move: Stripe-owned Bridge to expand Visa cards to 100+ countries

Visa’s next stablecoin move: Stripe-owned Bridge to expand Visa cards to 100+ countries

Visa is expanding its partnership with Stripe-owned Bridge to offer stablecoin-linked Visa cards in over 100 countries by year-end, after launching in 18 countries. The cards let users spend stablecoin balances at 175 million merchants, with some transactions settling on blockchain through Lead Bank. Mastercard and SoFi announced a similar stablecoin settlement option. Visa shares fell 0.25% in late trading.
Salesforce leadership breaks silence on Benioff ICE-joke backlash as AI fears bite

Salesforce leadership breaks silence on Benioff ICE-joke backlash as AI fears bite

Salesforce President Robin Washington told staff the company is “appropriately adjusting” after CEO Marc Benioff’s jokes about ICE drew internal criticism, according to audio from an all-hands meeting reviewed by Business Insider. Cofounder Parker Harris called Benioff’s remarks “a very bad joke.” Salesforce shares rose 4.3% Thursday, closing at $201.39. The company did not immediately respond to requests for comment.
Walmart’s PhonePe IPO: India fintech targets up to $10.5B valuation as Walmart trims stake

Walmart’s PhonePe IPO: India fintech targets up to $10.5B valuation as Walmart trims stake

PhonePe, Walmart’s India payments unit, is seeking a $9–10.5 billion IPO valuation, below its $12 billion private mark last year, sources said. The offer-for-sale aims to raise up to $1.05 billion, with Walmart, Microsoft, and Tiger Global selling stakes. No new shares will be issued. PhonePe reported losses of $158 million on revenue of $470 million for the half-year ended September 30.
6 March 2026
Silver price today: Why silver, SLV ETF and silver stocks fell before Friday’s jobs report

Silver price today: Why silver, SLV ETF and silver stocks fell before Friday’s jobs report

Silver fell 1.5% to around $82 a troy ounce in New York Thursday, with iShares Silver Trust and major miners also dropping after-hours as the dollar and Treasury yields rose. The dollar index gained 0.5% and 10-year yields hit a three-week high near 4.14%. Silver remains up over 16% for the year. Traders await Friday’s U.S. payrolls report for direction.
Intel faces fresh China scrutiny as senators press chipmaker over tool tests

Intel faces fresh China scrutiny as senators press chipmaker over tool tests

U.S. senators questioned Intel over testing chipmaking tools from ACM Research, citing national security risks tied to ACM’s China links. Intel said ACM tools are not used in its production. The inquiry comes as Intel considers offering its advanced 18A manufacturing process to outside customers. Lawmakers highlighted ACM’s business with sanctioned Chinese firms and its subsidiaries’ presence on U.S. sanctions lists.
Gold price slides as yields climb and the dollar firms; U.S. jobs report in focus

Gold price slides as yields climb and the dollar firms; U.S. jobs report in focus

Gold fell 1.2% to $5,076.59 an ounce Thursday as rising U.S. Treasury yields and a stronger dollar outweighed safe-haven demand. U.S. crude jumped 8.5% to $81.01 a barrel. The SPDR Gold Shares ETF dropped 1.18%, while the VanEck Gold Miners ETF slid 3.83%. U.S. jobless claims held steady at 213,000, with no sign of imminent Fed rate cuts.
6 March 2026
Palantir stock in focus: Pentagon’s Anthropic ban forces Maven AI rewrite

Palantir stock in focus: Pentagon’s Anthropic ban forces Maven AI rewrite

Palantir must rebuild its Maven Smart Systems software after the Pentagon ordered contractors to cut ties with Anthropic, whose Claude AI model underpins Maven, sources said. The Defense Department labeled Anthropic a “supply chain risk,” forcing removal from sensitive systems. Palantir’s contracts tied to Maven are potentially worth over $1 billion. Shares fell 0.3% to $152.67 on Thursday.
1 183 184 185 186 187 875

Stock Market Today

  • Live Cattle Prices Drop Amid Light Cash Trade and Lower Beef Stocks
    June 26, 2026, 3:57 PM EDT. Live cattle prices fell by 35 cents to $1.20 midday Friday, pressured by light cash trade volumes at $260 live and $408 dressed reported Wednesday. The Fed Cattle Exchange online auction recorded no sales on 1,636 head offered, with bids at $255. Feeder cattle futures also declined by $3.47 to $3.70. USDA data showed beef stocks at 403.474 million pounds at May's end, down 1.06% from last year. Wholesale boxed beef prices decreased, with Choice boxes down $4.22 to $392.10 and Select down $2.33 to $372.41. Federally inspected cattle slaughter rose slightly to 109,000 head Thursday but remained below last year's level. These factors combined indicate weakness in the cattle market heading into Friday's trading session.

Latest News

AT&T dividend yield near 5% puts cash flow back in the spotlight

AT&T dividend yield near 5% puts cash flow back in the spotlight

26 June 2026
AT&T (NYSE:T) rose 0.6% to $22.55 as investors weighed its 4.9% dividend yield and $8 billion 2026 buyback—together nearly 10% of equity value—against Q2 free-cash-flow guidance of $4.0–$4.5 billion, which would cover the dividend by just over 2x ahead of July 22 results.
Tesla (TSLA) swings lower with June drop wiping out $240 billion in market value

Tesla (TSLA) swings lower with June drop wiping out $240 billion in market value

26 June 2026
Tesla shares jumped 1.3% to $380.03 after a $68 billion intraday swing—exceeding Ford’s entire market value—but remain down 15% in June as investors weigh delivery data, FSD probes, and soaring AI spending; a $240 billion equity loss this month highlights the risk if Tesla’s premium stays tied to autonomy and software amid ongoing legal and regulatory scrutiny.
Go toTop